Literature DB >> 25979860

Altered cortical processing of observed pain in patients with fibromyalgia syndrome.

Nicholas Fallon1, Xiaoyun Li2, Yee Chiu3, Turo Nurmikko4, Andrej Stancak2.   

Abstract

UNLABELLED: Fibromyalgia syndrome (FMS) is characterized by widespread chronic pain, fatigue, sleep disorders, and cognitive-emotional disturbance. Patients with FMS exhibit increased sensitivity to experimental pain and pain-related cues, as well as deficits in emotional regulation. The present study investigated the spatiotemporal patterns of brain activations for observed pain in 19 patients with FMS and 18 age-matched, healthy control individuals using event-related potential analysis. Patients with FMS attributed greater pain and unpleasantness to pain pictures, relative to healthy control participants. An augmented late positive potential (LPP) component (>500 milliseconds) was found in patients viewing both pain and nonpain pictures, and this amplitude difference in the LPP covaried with perceived unpleasantness of pictures. Mid-latency potentials (250-450 milliseconds) demonstrated similar amplitude increases of positive potentials in the FMS patient group. By contrast, the short-latency positive potential (140 milliseconds) was reduced in patients with FMS relative to healthy control participants. Results suggest amplitude increases to mid- to long-latency cortical activations in patients with FMS, which are known to reflect emotional control and motivational salience of stimuli. PERSPECTIVE: Patients with FMS demonstrate increased activations associated with pain and nonpain pictures. The findings suggest that even innocuous, everyday visual stimuli with somatic connotations may challenge the emotional state of patients with FMS. Our study points toward the importance of cognitive-emotional therapeutic approaches for the treatment of FMS.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Electroencephalography; chronic pain; event-related potential; hypervigilance

Mesh:

Year:  2015        PMID: 25979860     DOI: 10.1016/j.jpain.2015.04.008

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  7 in total

1.  Differential efficiency of transcutaneous electrical nerve stimulation in dominant versus nondominant hands in fibromyalgia: placebo-controlled functional near-infrared spectroscopy study.

Authors:  Aykut Eken; Murat Kara; Bora Baskak; Ayşegül Baltacı; Didem Gökçay
Journal:  Neurophotonics       Date:  2017-09-05       Impact factor: 3.593

2.  Pain Catastrophising Affects Cortical Responses to Viewing Pain in Others.

Authors:  Nicholas Fallon; Xiaoyun Li; Andrej Stancak
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

3.  Increased Low- and High-Frequency Oscillatory Activity in the Prefrontal Cortex of Fibromyalgia Patients.

Authors:  Manyoel Lim; June Sic Kim; Dajung J Kim; Chun Kee Chung
Journal:  Front Hum Neurosci       Date:  2016-03-14       Impact factor: 3.169

4.  Altered theta oscillations in resting EEG of fibromyalgia syndrome patients.

Authors:  N Fallon; Y Chiu; T Nurmikko; A Stancak
Journal:  Eur J Pain       Date:  2017-07-31       Impact factor: 3.931

5.  Meta-analysis of ERP investigations of pain empathy underlines methodological issues in ERP research.

Authors:  Michel-Pierre Coll
Journal:  Soc Cogn Affect Neurosci       Date:  2018-10-25       Impact factor: 3.436

6.  Different Electrophysiological Responses to Pain-Related Visual Stimuli Between Fibromyalgia and Chronic low Back Pain Women: A Pilot Case-Control Study.

Authors:  Carlo Lai; Chiara Ciacchella; Gaia Romana Pellicano; Daniela Altavilla; Daniela Sambucini; Teresa Paolucci; Maria Laura Sorgi; Manuela Di Franco; Raoul Saggini; Paola Aceto
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-12-02

7.  The linkage between first-hand pain sensitivity and empathy for others' pain: Attention matters.

Authors:  Xiaoyun Li; Yang Liu; Qian Ye; Xuejing Lu; Weiwei Peng
Journal:  Hum Brain Mapp       Date:  2020-08-06       Impact factor: 5.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.